Evaluation of Therapeutic Effect of Limaixian in Treating HP-related Gastroduodenopathy of Childhood
- VernacularTitle:利迈先治疗儿童幽门螺杆菌相关性胃、十二指肠疾病的疗效评价
- Author:
Shusheng TANG
;
Xiaoyan HUANG
- Publication Type:Journal Article
- From:
China Pharmacy
2001;12(2):102-103
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To observe the therapeutic effect of limaixian in treating Helicobacterium pyloricus(HP)-related gastroduodenopathy of childhood and evaluate its role playing in triple short-term therapeutic scheme(TS scheme).METHODS：153 patients，who had definitely been diagnosed as HP-related gastroduodenopathy by gastroscopy or 13 C-UBT，were randomly divided into three groups(A，B，C)receiving ST scheme(omeprazole as the main drug).Group A：omeprazole 0.8mg/(kg*d)，metronidazole 20mg/(kg*d) and amoxycillin 40mg/(kg*d)； Group B omeprazole，metronidazole and klacid 15mg/(kg*d)； Group C：omeprazole，metronidazole and limaixian 15mg/(kg*d).Therapeutic course was 2 wks and gastroscopy or 13C-UBT were carried out 4 wks after discontinuation of drugs.RESULTS：(1)HP eradication rates of group A，B and C were 62.7％，92.1％ and 94.1％ respectively.The rates of group B,C were higher than that of group A.There were significant differences among three groups(X2=31.8,P<0.01).Group B showed no significant different with group C.(2) The remission rates of pain of group B and C were markedly higher than that of group A one and two wks after treatment (X2=19.3,P<0.05),there was no significant difference between group B and C.CONCLUSION:As an anti－ HP infection agent in TS scheme,limaixian is better than amoxycillin in therapeutic effect.Limaixian is comparable with imported klacid and inexpensive in price,it can be used as the first choice antibiotic in TS scheme.
